Table 2.
Baseline tumor characteristics
| Characteristics | |
|---|---|
| TNM staginga, n (%) | |
| T1 | 1 (4.2) |
| T2 | 5 (20.8) |
| T3 | 13 (54.2) |
| T4 | 4 (16.7) |
| N0 | 7 (29.2) |
| N1 | 10 (41.7) |
| N2 | 6 (25.0) |
| M0 | 2 (8.3) |
| M1 | 21 (87.5) |
| Location, n (%) | |
| Colon ascendens | 4 (16.7)b |
| Colon transversum | 2 (8.3) |
| Colon descendens | 0 (0) |
| Colon sigmoideum | 5 (20.8)b |
| Rectum | 15 (62.5) |
| Hepatic metastases, n ± SD, range, median | 2.0±1.9, 1–9, 2 |
| Short axis diameter of IRE-treated hepatic metastases, cm ± SD, range, median | 2.3±1.1, 0.5–4.5, 2 |
Note:
a
Missing data for one patient;
b
one case of simultaneous colon ascendens and colon sigmoideum.
Abbreviation: IRE, irreversible electroporation.